Hoppa till innehåll

Författare: Mia

Evrysdi (Risdiplam) receives positive CHMP opinion for spinal muscular atrophy (SMA) treatment . The first only oral treatment at home for patients with spinal muscular atrophy

We received a great pressrelease from Roche. Risdiplam is a milestone ahead.   Basel, 26 February 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today…